Header Logo

Beverly Sha

TitleProfessor
InstitutionRush University, Rush Medical College
DepartmentInternal Medicine, Division of Infectious Diseases
AddressChicago IL 60612
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My Scopus ID is 7005779955.
    My NIH COMMONS name is BSHA123

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. McNulty MC, Stanford KA, Eller D, Sha BE, Purim-Shem-Tov Y, Kishen E, Glick N, Hunt B, Lin JY, Maheswaran A, Galvin S, Turelli R, Schmitt J, Pitrak D. Concurrent Testing for COVID-19 and HIV Infection at 6 High-Volume Emergency Departments in a Priority Jurisdiction for Ending the HIV Epidemic in the United States. J Acquir Immune Defic Syndr. 2023 12 01; 94(4):364-370. PMID: 37884056.
      Citations:    
    2. Friedman EE, Shankaran S, Devlin SA, Kishen EB, Mason JA, Sha BE, Ridgway JP. Development of a predictive model for identifying women vulnerable to HIV in Chicago. BMC Womens Health. 2023 Jun 16; 23(1):313. PMID: 37328764.
      Citations:    
    3. Schnittman SR, Lu MT, Mayrhofer T, Burdo TH, Fitch KV, McCallum S, Fulda ES, Zanni MV, Foldyna B, Malvestutto C, Fichtenbaum CJ, Aberg JA, Bloomfield GS, Overton ET, Currier J, Tebas P, Sha BE, Ribaudo HJ, Flynn JM, Douglas PS, Erlandson KM, Grinspoon SK. Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV). Clin Infect Dis. 2023 02 08; 76(3):e613-e621. PMID: 35975297.
      Citations:    
    4. Maaske J, Sproule S, Falsey AR, Sobieszczyk ME, Luetkemeyer AF, Paulsen GC, Riddler SA, Robb ML, Rolle CP, Sha BE, Tong T, Ahani B, Aksyuk AA, Bansal H, Egan T, Jepson B, Padilla M, Patel N, Shoemaker K, Stanley AM, Swanson PA, Wilkins D, Villafana T, Green JA, Kelly EJ. Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated. Front Immunol. 2022; 13:1062067. PMID: 36713413.
      Citations:    
    5. Whitney E, Pitrak D, Beavis KG, Moore NM, Shankaran S, Abeleda AP, Schmitt J, Sha BE. Utility of the Signal-to-Cutoff Ratio and Antigen Index from Fourth- and Fifth-Generation HIV-1/HIV-2 Antigen/Antibody Assays for the Diagnosis of Acute HIV Infection: Applicability for Real-Time Use for Immediate Initiation of Antiretroviral Therapy. J Clin Microbiol. 2022 12 21; 60(12):e0120422. PMID: 36448814.
      Citations:    
    6. Ash MK, Bhimalli PP, Cho BK, Mattamana BB, Gambut S, Tarhoni I, Fhied CL, Reyes AF, Welninski SJ, Arivalagan J, Negr?o F, Goel R, Beck TL, Hope TJ, Sha BE, Goo YA, Al-Harthi L, Mamede JI, Borgia JA, Kelleher NL, Schneider JR. Bulk IgG glycosylation predicts COVID-19 severity and vaccine antibody response. Cell Rep. 2022 12 13; 41(11):111799. PMID: 36493786.
      Citations:    
    7. Forte E, Des Soye BJ, Melani RD, Hollas MAR, Kafader JO, Sha BE, Schneider JR, Kelleher NL. Divergent Antibody Repertoires Found for Omicron versus Wuhan SARS-CoV-2 Strains Using Ig-MS. J Proteome Res. 2022 12 02; 21(12):2987-2997. PMID: 36343328.
      Citations:    
    8. Barbian HJ, Seaton MS, Narasipura SD, Wallace J, Rajan R, Sha BE, Al-Harthi L. ?-catenin regulates HIV latency and modulates HIV reactivation. PLoS Pathog. 2022 03; 18(3):e1010354. PMID: 35255110.
      Citations:    
    9. Keizur E, Robinson E, Sha BE, Aziz M, Shankaran S. Effectiveness of an electronic health record model for HIV pre-exposure prophylaxis. Int J STD AIDS. 2022 04; 33(5):499-502. PMID: 35225082.
      Citations:    
    10. Melani RD, Des Soye BJ, Kafader JO, Forte E, Hollas M, Blagojevic V, Negr?o F, McGee JP, Drown B, Lloyd-Jones C, Seckler HS, Camarillo JM, Compton PD, LeDuc RD, Early B, Fellers RT, Cho BK, Mattamana BB, Goo YA, Thomas PM, Ash MK, Bhimalli PP, Al-Harthi L, Sha BE, Schneider JR, Kelleher NL. Next-Generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire. J Proteome Res. 2022 01 07; 21(1):274-288. PMID: 34878788.
      Citations:    
    11. Melani RD, Soye BJD, Kafader JO, Forte E, Hollas M, Blagojevic V, Negr?o F, McGee JP, Drown B, Lloyd-Jones C, Seckler HS, Camarillo JM, Compton PD, LeDuc RD, Early B, Fellers RT, Cho BK, Mattamana BB, Goo YA, Thomas PM, Ash MK, Bhimalli PP, Al-Harthi L, Sha BE, Schneider JR, Kelleher NL. Next-generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire. medRxiv. 2021 Jul 07. PMID: 34268518.
      Citations:    
    12. Virdi AK, Wallace J, Barbian H, Richards MH, Ritz EM, Sha B, Al-Harthi L. CD32 is enriched on CD4dimCD8bright T cells. PLoS One. 2020; 15(9):e0239157. PMID: 32960910.
      Citations:    
    13. Wallace J, Narasipura SD, Sha BE, French AL, Al-Harthi L. Canonical Wnts Mediate CD8+ T Cell Noncytolytic Anti-HIV-1 Activity and Correlate with HIV-1 Clinical Status. J Immunol. 2020 10 15; 205(8):2046-2055. PMID: 32887752.
      Citations:    
    14. Rhee Y, Sha BE, Santos CAQ. Optimizing Vaccination in Adult Patients With Liver Disease and Liver Transplantation. Clin Liver Dis (Hoboken). 2020 Feb; 15(2):63-68. PMID: 32226617.
      Citations:    
    15. McNulty M, Schmitt J, Friedman E, Hunt B, Tobin A, Maheswaran AB, Lin J, Novak R, Sha B, Rolfsen N, Moswin A, Rose B, Pitrak D, Glick N. Implementing Rapid Initiation of Antiretroviral Therapy for Acute HIV Infection Within a Routine Testing and Linkage to Care Program in Chicago. J Int Assoc Provid AIDS Care. 2020 Jan-Dec; 19:2325958220939754. PMID: 32734805.
      Citations:    
    16. Sha BE, Kniuksta R, Exner K, Kishen E, Shankaran S, Williams B, Aziz M, Lai R, Purim-Shem-Tov Y. Evolution of an Electronic Health Record Based-Human Immunodeficiency Virus (HIV) Screening Program in an Urban Emergency Department for Diagnosing Acute and Chronic HIV Infection. J Emerg Med. 2019 11; 57(5):732-739. PMID: 31629580.
      Citations:    
    17. Sha BE. Adult Immunization Update. JAMA. 2019 Sep 17; 322(11):1096-1097. PMID: 31424523.
      Citations:    
    18. Nyaku AN, Zheng L, Gulick RM, Olefsky M, Berzins B, Wallis CL, Godfrey C, Sax PE, Acosta EP, Haas DW, Smith KY, Sha BE, Van Dam CN, Taiwo BO. Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500?000 copies/mL: week 48 outcomes from ACTG 5353. J Antimicrob Chemother. 2019 05 01; 74(5):1376-1380. PMID: 30668695.
      Citations:    
    19. Fletcher FE, Vidrine DJ, Trejo MB, Molina Y, Sha BE, Floyd BR, Sarhene N, Mator J, Matthews AK. "You Come Back to the Same Ole Shit:" A Qualitative Study of Smoking Cessation Barriers among Women Living with HIV: Implications for Intervention Development. J Health Dispar Res Pract. 2019; 12(2):106-122. PMID: 32963893.
      Citations:    
    20. Taiwo BO, Zheng L, Stefanescu A, Nyaku A, Bezins B, Wallis CL, Godfrey C, Sax PE, Acosta E, Haas D, Smith KY, Sha B, Van Dam C, Gulick RM. ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants With HIV-1 RNA <500000 Copies/mL. Clin Infect Dis. 2018 05 17; 66(11):1689-1697. PMID: 29253097.
      Citations:    
    21. Khawcharoenporn T, Damronglerd P, Chunloy K, Sha BE. Enhanced inpatient rounds, appointment reminders, and patient education improved HIV care engagement following hospital discharge. Int J STD AIDS. 2018 06; 29(7):641-649. PMID: 29402187.
      Citations:    
    22. White DAE, Giordano TP, Pasalar S, Jacobson KR, Glick NR, Sha BE, Mammen PE, Hunt BR, Todorovic T, Moreno-Walton L, Adomolga V, Feaster DJ, Branson BM. Acute HIV Discovered During Routine HIV Screening With HIV Antigen-Antibody Combination Tests in 9 US Emergency Departments. Ann Emerg Med. 2018 07; 72(1):29-40.e2. PMID: 29310870.
      Citations:    
    23. Kuniholm MH, Liang H, Anastos K, Gustafson D, Kassaye S, Nowicki M, Sha BE, Pawlowski EJ, Gange SJ, Aouizerat BE, Pushkarsky T, Bukrinsky MI, Prasad VR. Association of a 3' untranslated region polymorphism in proprotein convertase subtilisin/kexin type 9 with HIV viral load and CD4+ levels in HIV/hepatitis C virus coinfected women. AIDS. 2017 11 28; 31(18):2483-2492. PMID: 29120899.
      Citations:    
    24. Burke-Miller JK, Weber K, Cohn SE, Hershow RC, Sha B, French AL, Cohen MH. Measurement of Neighborhood Context in an Urban Cohort of HIV-infected or at risk Low-Income Women. J Poverty. 2017; 21(1):80-96. PMID: 29230088.
      Citations:    
    25. Burke-Miller JK, Weber K, Cohn SE, Hershow RC, Sha BE, French AL, Cohen MH. Neighborhood community characteristics associated with HIV disease outcomes in a cohort of urban women living with HIV. AIDS Care. 2016 10; 28(10):1274-9. PMID: 27098593.
      Citations:    
    26. Cheng JW, Hayden MK, Singh K, Heimler I, Gee JE, Proia L, Sha BE. Burkholderia pseudomallei Infection in US Traveler Returning from Mexico, 2014. Emerg Infect Dis. 2015 Oct; 21(10):1884-5. PMID: 26401597.
      Citations:    
    27. Sha BE, Tierney C, Sun X, Stek A, Cohn SE, Coombs RW, Bastow B, Aweeka FT. PHARMACOKINETIC EXPOSURE AND VIROLOGIC RESPONSE IN HIV-1 INFECTED PREGNANT WOMEN TREATED WITH LOPINAVIR/RITONAVIR: AIDS CLINICAL TRIALS GROUP PROTOCOL A5153S: A SUBSTUDY TO A5150. Jacobs J AIDS HIV. 2015; 1(1). PMID: 26878071.
      Citations:    
    28. Swanson B, Keithley JK, Johnson A, Fogg L, Adeyemi O, Sha BE, Snell KA. Acupuncture to Reduce HIV-Associated Inflammation. Evid Based Complement Alternat Med. 2015; 2015:908538. PMID: 25922615.
      Citations:    
    29. Conant MM, Sha BE, Proia LA. Use of posaconazole delayed-release tablets for treatment of invasive aspergillosis. Mycoses. 2015 May; 58(5):313-4. PMID: 25728539.
      Citations:    
    30. Williams B, Hanson A, Sha B. Diffuse Desquamating Rash Following Exposure to Vancomycin-Impregnated Bone Cement. Ann Pharmacother. 2014 Aug; 48(8):1061-1065. PMID: 24740467.
      Citations:    
    31. Swanson B, Keithley JK, Sha BE, Fogg L, Nerad J, Novak RM, Adeyemi O, Spear GT. Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial. Altern Ther Health Med. 2011 Mar-Apr; 17(2):30-5. PMID: 21717822.
      Citations:    
    32. Sha BE, Tierney C, Cohn SE, Sun X, Coombs RW, Frenkel LM, Kalams SA, Aweeka FT, Bastow B, Bardeguez A, Kmack A, Stek A. Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150. HIV Clin Trials. 2011 Jan-Feb; 12(1):9-23. PMID: 21388937.
      Citations:    
    33. Fu J, Sha BE, Thomas LL. HIV-1-infected peripheral blood mononuclear cells enhance neutrophil survival and HLA-DR expression via increased production of GM-CSF: implications for HIV-1 infection. J Acquir Immune Defic Syndr. 2011 Jan 01; 56(1):16-25. PMID: 20975570.
      Citations:    
    34. Huhn GD, Badri S, Vibhakar S, Tverdek F, Crank C, Lubelchek R, Max B, Simon D, Sha B, Adeyemi O, Herrera P, Tenorio A, Kessler H, Barker D. Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution. AIDS Res Ther. 2010 Dec 14; 7:44. PMID: 21156072.
      Citations:    
    35. Corrigan MA, Atkinson KM, Sha BE, Crank CW. Evaluation of pharmacy-implemented medication reconciliation directed at antiretroviral therapy in hospitalized HIV/AIDS patients. Ann Pharmacother. 2010 Jan; 44(1):222-3. PMID: 20040697.
      Citations:    
    36. Swanson B, Sha BE, Keithley JK, Fogg L, Nerad J, Novak R, Adeyemi O. Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Spectroscopy in Medically-Underserved HIV-Infected Persons. J Clin Lipidol. 2009 Dec 01; 3(6):379-384. PMID: 20161509.
      Citations:    
    37. Lin MY, Chihara S, Smith KY, Kessler HA, Sha BE, Proia LA. Classic pyomyositis of the extremities as an unusual manifestation of Blastomyces dermatitidis: a report of two cases. Mycoses. 2010 Jul; 53(4):356-9. PMID: 19496934.
      Citations:    
    38. Adeyemi OM, Rezai K, Akimov S, Hwang J, Sha BE, Kessler HA. Coronary artery calcification on electron beam computed tomography: a 6-year follow-up study of HIV-infected patients. J Acquir Immune Defic Syndr. 2008 Sep 01; 49(1):113-4. PMID: 18725810.
      Citations:    
    39. Spear GT, Zariffard MR, Cohen MH, Sha BE. Vaginal IL-8 levels are positively associated with Candida albicans and inversely with lactobacilli in HIV-infected women. J Reprod Immunol. 2008 Jun; 78(1):76-9. PMID: 18243333.
      Citations:    
    40. Davey RT, Pertel PE, Benson A, Cassell DJ, Gazzard BG, Holodniy M, Lalezari JP, Levy Y, Mitsuyasu RT, Palella FJ, Pollard RB, Rajagopalan P, Saag MS, Salata RA, Sha BE, Choudhri S. Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy. J Interferon Cytokine Res. 2008 Feb; 28(2):89-100. PMID: 18279104.
      Citations:    
    41. Sha BE, Gawel SH, Hershow RC, Passaro D, Augenbraun M, Darragh TM, Stek A, Golub ET, Mph LC, Moxley MD, Weber KM, Watts DH. Analysis of standard methods for diagnosing vaginitis: HIV infection does not complicate the diagnosis of vaginitis. J Low Genit Tract Dis. 2007 Oct; 11(4):240-50. PMID: 17917568.
      Citations:    
    42. Duckro AN, Sha BE, Jakate S, Hayden MK, Simon DM, Saltzberg SN, Arai S, Kessler HA. Herpes simplex virus hepatitis: expanding the spectrum of disease. Transpl Infect Dis. 2006 Sep; 8(3):171-6. PMID: 16913977.
      Citations:    
    43. Zariffard MR, Sha BE, Wang QJ, Chen HY, Bremer J, Cohen MH, Spear GT. Relationship of U1 cell HIV-stimulatory activity to bacterial vaginosis and HIV genital tract virus load. AIDS Res Hum Retroviruses. 2005 Nov; 21(11):945-8. PMID: 16386111.
      Citations:    
    44. Sha BE, Chen HY, Wang QJ, Zariffard MR, Cohen MH, Spear GT. Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women. J Clin Microbiol. 2005 Sep; 43(9):4607-12. PMID: 16145114.
      Citations:    
    45. Zariffard MR, Novak RM, Lurain N, Sha BE, Graham P, Spear GT. Induction of tumor necrosis factor- alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis. J Infect Dis. 2005 Jun 01; 191(11):1913-21. PMID: 15871126.
      Citations:    
    46. Watts DH, Fazzari M, Fazarri M, Minkoff H, Hillier SL, Sha B, Glesby M, Levine AM, Burk R, Palefsky JM, Moxley M, Ahdieh-Grant L, Strickler HD. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis. 2005 Apr 01; 191(7):1129-39. PMID: 15747249.
      Citations:    
    47. Sha BE, Zariffard MR, Wang QJ, Chen HY, Bremer J, Cohen MH, Spear GT. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis. 2005 Jan 01; 191(1):25-32. PMID: 15592999.
      Citations:    
    48. Rezai K, Kuchipudi S, Chundi V, Ariga R, Loew J, Sha BE. Kikuchi-Fujimoto disease: hydroxychloroquine as a treatment. Clin Infect Dis. 2004 Dec 15; 39(12):e124-6. PMID: 15578393.
      Citations:    
    49. Swanson B, Keithley JK, Zeller JM, Sha BE. Lack of association between dyslipidemia and insulin resistance in HIV-infected persons treated with highly active antiretroviral therapy. Nutrition. 2004 Nov-Dec; 20(11-12):1022-5. PMID: 15561494.
      Citations:    
    50. Sha BE, Onorato M, Bartlett JA, Bosch RJ, Aga E, Nokta M, Adams EM, Li XD, Eldridge J, Pollard RB. Safety and immunogenicity of a polyvalent peptide C4-V3 HIV vaccine in conjunction with IL-12. AIDS. 2004 May 21; 18(8):1203-6. PMID: 15166537.
      Citations:    
    51. Patel SM, Johnson S, Belknap SM, Chan J, Sha BE, Bennett C. Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals. J Acquir Immune Defic Syndr. 2004 Feb 01; 35(2):120-5. PMID: 14722442.
      Citations:    
    52. Tenorio AR, Smith KY, Kuritzkes DR, Sha BE, Donoval B, Young R, Jennings C, Bremer J, Shott S, Landay A, Kessler HA. HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course. J Acquir Immune Defic Syndr. 2003 Dec 15; 34(5):491-6. PMID: 14657759.
      Citations:    
    53. Kalayjian RC, Landay A, Pollard RB, Taub DD, Gross BH, Francis IR, Sevin A, Pu M, Spritzler J, Chernoff M, Namkung A, Fox L, Martinez A, Waterman K, Fiscus SA, Sha B, Johnson D, Slater S, Rousseau F, Lederman MM. Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J Infect Dis. 2003 Jun 15; 187(12):1924-33. PMID: 12792869.
      Citations:    
    54. Swanson B, Keithley JK, Zeller JM, Sha BE. A pilot study of the safety and efficacy of supplemental arginine to enhance immune function in persons with HIV/AIDS. Nutrition. 2002 Jul-Aug; 18(7-8):688-90. PMID: 12093460.
      Citations:    
    55. Sha BE, Valdez H, Gelman RS, Landay AL, Agosti J, Mitsuyasu R, Pollard RB, Mildvan D, Namkung A, Ogata-Arakaki DM, Fox L, Estep S, Erice A, Kilgo P, Walker RE, Bancroft L, Lederman MM. Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2. AIDS Res Hum Retroviruses. 2002 Jun 10; 18(9):661-5. PMID: 12079562.
      Citations:    
    56. Battle-Miller K, Eby CA, Landay AL, Cohen MH, Sha BE, Baum LL. Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1--infected women. J Infect Dis. 2002 Feb 15; 185(4):439-47. PMID: 11865395.
      Citations:    
    57. Hashemi FB, Mollenhauer J, Madsen LD, Sha BE, Nacken W, Moyer MB, Sorg C, Spear GT. Myeloid-related protein (MRP)-8 from cervico-vaginal secretions activates HIV replication. AIDS. 2001 Mar 09; 15(4):441-9. PMID: 11242140.
      Citations:    
    58. Sha BE, Proia LA, Kessler HA. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers. JAMA. 2000 Dec 06; 284(21):2723. PMID: 11105176.
      Citations:    
    59. Swanson B, Hershow RC, Sha BE, Benson CA, Cohen M, Gunfeld C. Body composition in HIV-infected women. Nutrition. 2000 Nov-Dec; 16(11-12):1064-8. PMID: 11118826.
      Citations:    
    60. Tenorio AR, Irlanda IE, Narkiewicz E, Smith KY, Kessler HA, Sha BE. Efficacy and safety of the combination of efavirenz and abacavir in HIV-infected patients failing antiretroviral therapy. AIDS. 2000 Jul 07; 14(10):1470-1. PMID: 10930173.
      Citations:    
    61. Sha BE, Johnson VA, Kendall MA, Haubrich R, Nokta M, Lamb K, Zackin RA, Nail CD, Currier JS. Absence of virological changes after acute febrile illnesses in two patients with undetectable pre-illness plasma HIV-1-RNA levels. AIDS. 2000 Apr 14; 14(6):746-8. PMID: 10807200.
      Citations:    
    62. Olinger GG, Hashemi FB, Sha BE, Spear GT. Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1. AIDS. 1999 Oct 01; 13(14):1905-12. PMID: 10513649.
      Citations:    
    63. Al-Harthi L, Roebuck KA, Olinger GG, Landay A, Sha BE, Hashemi FB, Spear GT. Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression. J Acquir Immune Defic Syndr. 1999 Jul 01; 21(3):194-202. PMID: 10421242.
      Citations:    
    64. Jacobson JM, Spritzler J, Fox L, Fahey JL, Jackson JB, Chernoff M, Wohl DA, Wu AW, Hooton TM, Sha BE, Shikuma CM, MacPhail LA, Simpson DM, Trapnell CB, Basgoz N. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. J Infect Dis. 1999 Jul; 180(1):61-7. PMID: 10353862.
      Citations:    
    65. Olivero OA, Shearer GM, Chougnet CA, Kovacs AA, Landay AL, Baker R, Stek AM, Khoury MM, Proia LA, Kessler HA, Sha BE, Tarone RE, Poirier MC. Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS. 1999 May 28; 13(8):919-25. PMID: 10371172.
      Citations:    
    66. Valdez H, Purvis S, Asaad R, Valerio I, Sha BE, Landay AL, Lederman MM. Levels of proinflammatory cytokines in plasma after pneumoccoccal immunization in human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol. 1999 May; 6(3):427-8. PMID: 10225849.
      Citations:    
    67. Al-Harthi L, Spear GT, Hashemi FB, Landay A, Sha BE, Roebuck KA. A human immunodeficiency virus (HIV)-inducing factor from the female genital tract activates HIV-1 gene expression through the kappaB enhancer. J Infect Dis. 1998 Nov; 178(5):1343-51. PMID: 9780254.
      Citations:    
    68. Hershow RC, Kalish LA, Sha B, Till M, Cohen M. Hepatitis C virus infection in Chicago women with or at risk for HIV infection: evidence for sexual transmission. Sex Transm Dis. 1998 Nov; 25(10):527-32. PMID: 9858348.
      Citations:    
    69. Spear GT, Sha BE, Saarloos MN, Benson CA, Rydman R, Massad LS, Gilmore R, Landay AL. Chemokines are present in the genital tract of HIV-seropositive and HIV-seronegative women: correlation with other immune mediators. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15; 18(5):454-9. PMID: 9715841.
      Citations:    
    70. Takefman DM, Sullivan BL, Sha BE, Spear GT. Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysis. Virology. 1998 Jul 05; 246(2):370-8. PMID: 9657955.
      Citations:    
    71. Sha BE, D'Amico RD, Landay AL, Spear GT, Massad LS, Rydman RJ, Warner NA, Padnick J, Ackatz L, Charles LA, Benson CA. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Nov 01; 16(3):161-8. PMID: 9390567.
      Citations:    
    72. Spear GT, al-Harthi L, Sha B, Saarloos MN, Hayden M, Massad LS, Benson C, Roebuck KA, Glick NR, Landay A. A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women. AIDS. 1997 Sep; 11(11):1319-26. PMID: 9302440.
      Citations:    
    73. Fowke KR, D'Amico R, Chernoff DN, Pottage JC, Benson CA, Sha BE, Kessler HA, Landay AL, Shearer GM. Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients. AIDS. 1997 Jul; 11(8):1013-21. PMID: 9223736.
      Citations:    
    74. Sullivan BL, Knopoff EJ, Saifuddin M, Takefman DM, Saarloos MN, Sha BE, Spear GT. Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo. J Immunol. 1996 Aug 15; 157(4):1791-8. PMID: 8759769.
      Citations:    
    75. Sha BE, Benson CA, Pottage JC, Urbanski PA, Daugherty SR, Kessler HA. HIV infection in women: an observational study of clinical characteristics, disease progression, and survival for a cohort of women in Chicago. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15; 8(5):486-95. PMID: 7697446.
      Citations:    
    76. Sullivan JF, Kessler HA, Sha BE. False-positive HIV test: implications for the patient. JAMA. 1993 Jun 09; 269(22):2847. PMID: 8497085.
      Citations:    
    77. Sha BE, Benson CA, Deutsch T, Noskin GA, Murphy RL, Pottage JC, Finn WG, Roth SI, Kessler HA. Pneumocystis carinii choroiditis in patients with AIDS: clinical features, response to therapy, and outcome. J Acquir Immune Defic Syndr (1988). 1992 Oct; 5(10):1051-8. PMID: 1453321.
      Citations:    
    78. Pottage JC, Benson CA, Sha BE, Urbanski P, Kessler HA. Treatment of patients with advanced HIV infection and zidovudine intolerance with dideoxyinosine. AIDS. 1992 Jul; 6(7):748-9. PMID: 1503699.
      Citations:    
    79. Sha BE, Harris AA, Benson CA, Atkinson WL, Urbanski PA, Stewart JA, Williams WW, Murphy RL, Phair JP, Levin SA, et al. Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. J Infect Dis. 1991 Nov; 164(5):973-5. PMID: 1682395.
      Citations:    
    80. Sha BE, Benson CA, Deutsch TA, Urbanski PA, Phair JP, Kessler HA. Suppression of cytomegalovirus retinitis in persons with AIDS with high-dose intravenous acyclovir. J Infect Dis. 1991 Oct; 164(4):777-80. PMID: 1654361.
      Citations:    
    81. Pottage JC, Sha BE. Development of histoplasmosis in a human immunodeficiency virus-infected patient receiving fluconazole. J Infect Dis. 1991 Sep; 164(3):622-3. PMID: 1869858.
      Citations:    
    Sha's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (387)
    Explore
    _
    Co-Authors (21)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _